Shareholders approve increase in Alkermes equity plan by 5.9M shares

Shareholders approved the 2018 Plan, with the votes cast as follows: 128,147,910 votes for; 12,952,836 votes against; 69,229 votes abstaining; and 7,911,628 broker non-votes.

By separate resolutions, shareholders elected the following directors, each to serve on the Company’s board of directors (the “Board”) for a one-year term until the Company’s 2027 annual general meeting of shareholders, with the votes cast as follows:

Shareholders ratified, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the independent auditor and accounting firm of the Company, and authorized, in a binding vote, the Audit and Risk Committee of the Board to set the independent auditor and accounting firm’s remuneration, with the votes cast as follows: 146,222,286 votes for; 2,812,663 votes against; and 46,653 votes abstaining.

Shareholders renewed Board authority to allot and issue shares under Irish law, with the votes cast as follows: 148,661,934 votes for; 382,138 votes against; and 37,531 votes abstaining.

Shareholders approved, in a non-binding, advisory vote, the compensation of the Company’s named executive officers, with the votes cast as follows: 139,234,176 votes for; 1,787,311 votes against; 148,488 votes abstaining; and 7,911,628 broker non-votes.

Shareholders renewed Board authority to disapply the statutory pre-emption rights that would otherwise apply under Irish law, with the votes cast as follows: 146,903,611 votes for; 2,086,009 votes against; and 91,983 votes abstaining.